Status: Recruiting
Phase II Study of RC1416 Injection in COPD
This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of RC1416 injection in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Participants needed: 180
Trial details
Phase: Phase 2Age: 40-85Biological sex: AllType: InterventionalSponsor: Nanjing RegeneCore Biotech Co., Ltd.Updated: Apr 17, 2026Locations: 41
Eligibility criteria
Aged 40 to 85 years (inclusive) at the time of signing the informed consent form... [+8]
A current diagnosis of asthma or a history of asthma. [+8]